← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2015Last known activity
Aug 1, 2016
Acquired by Spectrum Pharmaceuticals → Repligen Corporation on May 9, 2019
Timeline
2000s
- Jun 1, 2007
ImmunGene Inc.— Founded
2010s
- Jun 27, 2017
Repligen Corporation— Now
- May 9, 2019
Spectrum Pharmaceuticals— Acquired By
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT02847949CollaboratorPhase 2Aug 1, 2016
- NCT02847949Lead sponsorPhase 2Aug 1, 2016
- NCT02519270Study directorPhase 1Dec 1, 2015
- NCT02519270Lead sponsorPhase 1Dec 1, 2015
- NCT02519270CollaboratorPhase 1Dec 1, 2015
Details
- Founded
- Thousand Oaks, CA, US Jun 1, 2007
- Last known activity
- Aug 1, 2016